418 related articles for article (PubMed ID: 18197006)
21. [Postoperative adjuvant therapy for premenopausal patients with breast cancer].
Kurebayashi J
Nihon Rinsho; 2006 Oct; 64(10):1963-9. PubMed ID: 17037375
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer adjuvant endocrine therapy.
Cigler T; Goss PE
Cancer J; 2007; 13(3):148-55. PubMed ID: 17620763
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
Ortmann O; Cufer T; Dixon JM; Maass N; Marchetti P; Pagani O; Pronzato P; Semiglazov V; Spano JP; Vrdoljak E; Wildiers H
Breast; 2009 Feb; 18(1):2-7. PubMed ID: 19036588
[TBL] [Abstract][Full Text] [Related]
24. [Recent progress of endocrine therapy in breast cancer].
Nomura Y
Gan To Kagaku Ryoho; 1992 Jun; 19(6):783-9. PubMed ID: 1605654
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant therapy with GnRH agonists/tamoxifen in breast cancer should be a good council for patients with hormone receptor-positive tumours and wish to preserve fertility.
Franco JG; Oliveira JB; Petersen CG; Mauri AL; Baruffi R; Cavagna M
Med Hypotheses; 2012 Apr; 78(4):442-5. PubMed ID: 22284634
[TBL] [Abstract][Full Text] [Related]
26. Goserelin (Zoladex)--its role in early breast cancer in pre- and perimenopausal women.
Jonat W
Br J Cancer; 2001 Nov; 85 Suppl 2(Suppl 2):1-5. PubMed ID: 11900209
[TBL] [Abstract][Full Text] [Related]
27. The Role of Ovarian Suppression in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer.
Jain S; Santa-Maria CA; Gradishar WJ
Oncology (Williston Park); 2015 Jul; 29(7):473-8, 481. PubMed ID: 26178334
[TBL] [Abstract][Full Text] [Related]
28. Ovarian ablation in the adjuvant treatment of premenopausal and perimenopausal breast cancer.
Sainsbury R
Br J Surg; 2003 May; 90(5):517-26. PubMed ID: 12734855
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant therapy of breast cancer.
Kaklamani VG; Gradishar WJ
Cancer Invest; 2005; 23(6):548-60. PubMed ID: 16203663
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant hormonal therapy for premenopausal women with breast cancer.
Emens LA; Davidson NE
Clin Cancer Res; 2003 Jan; 9(1 Pt 2):486S-94S. PubMed ID: 12538505
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant endocrine treatment of early breast cancer.
Lønning PE
Hematol Oncol Clin North Am; 2007 Apr; 21(2):223-38. PubMed ID: 17512446
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial.
Sverrisdottir A; Nystedt M; Johansson H; Fornander T
Breast Cancer Res Treat; 2009 Oct; 117(3):561-7. PubMed ID: 19153828
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant therapy of breast cancer.
Kaklamani VG; Gradishar WJ
Minerva Ginecol; 2005 Oct; 57(5):521-36. PubMed ID: 16205597
[TBL] [Abstract][Full Text] [Related]
34. Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.
; Cuzick J; Ambroisine L; Davidson N; Jakesz R; Kaufmann M; Regan M; Sainsbury R
Lancet; 2007 May; 369(9574):1711-23. PubMed ID: 17512856
[TBL] [Abstract][Full Text] [Related]
35. Serum selenium measurements in women with early-stage breast cancer with and without chemotherapy-induced ovarian failure.
Breedlove HA; Smith AM; Burk RF; Hill KE; Shapiro CL
Breast Cancer Res Treat; 2006 Jun; 97(3):225-30. PubMed ID: 16791483
[TBL] [Abstract][Full Text] [Related]
36. Amenorrhea following chemotherapy for breast cancer: effect on disease-free survival.
Collichio F; Pandya K
Oncology (Williston Park); 1994 Dec; 8(12):45-52. PubMed ID: 7888312
[TBL] [Abstract][Full Text] [Related]
37. New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients.
Del Mastro L; Rossi G; Lambertini M; Poggio F; Pronzato P
Cancer Treat Rev; 2016 Jan; 42():18-23. PubMed ID: 26613834
[TBL] [Abstract][Full Text] [Related]
38. [Menstrual abnormality in patients with breast cancer receiving adjuvant endocrine-chemotherapy].
Yasumura T; Oka T; Honjo H; Okada H
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2947-52. PubMed ID: 3140733
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant endocrine therapy for premenopausal women with early breast cancer.
Dellapasqua S; Colleoni M; Gelber RD; Goldhirsch A
J Clin Oncol; 2005 Mar; 23(8):1736-50. PubMed ID: 15755982
[No Abstract] [Full Text] [Related]
40. [Adjuvant chemotherapy of premenopausal breast cancer with LH-RH analogue for ovarian protection--a case report].
Asaga S; Ando J; Arai T; Fujii H
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1069-72. PubMed ID: 16044976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
